Use of drug-eluting versus bare-metal stents after an acute coronary syndrome in Portugal: The EURHOBOP study

Revista Portuguesa de Cardiologia

Volumn 34, Issue 7-8, 2015, Pages 449-456

  Barros, Vítor ^a   Pereira, Marta ^a,b   Araújo, Carla ^a,b,c   Braga, Pedro ^d   Azevedo, Ana ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c Centro Hospitalar de Tras os Montes e Alto Douro   (Portugal)

^d CENTRO HOSPITALAR DE VILA NOVA DE GAIA ESPINHO   (Portugal)

Author keywords

Acute coronary syndrome; Coronary angioplasty; Myocardial infarction; Stent; Unstable angina

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ANEMIA; ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; BARE METAL STENT; CARDIAC PATIENT; CATHETERIZATION; CEREBROVASCULAR ACCIDENT; DRUG ELUTING STENT; FEMALE; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PORTUGAL; RETROSPECTIVE STUDY; RIGHT CORONARY ARTERY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; VERY ELDERLY; CLINICAL TRIAL; COMPARATIVE STUDY; MIDDLE AGED; MULTICENTER STUDY; PROSTHESIS DESIGN; STENT;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PORTUGAL; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; STENTS;

EID: 84983155193     PISSN: 08702551     EISSN: 21742030     Source Type: Journal    
DOI: 10.1016/j.repc.2015.03.006     Document Type: Article

References (41)

1. A. Kumar, and C.P. Cannon Acute coronary syndromes: diagnosis and management, Part II Mayo Clin Proc 84 2009 1021 1036
2. G.N. Levine, E.R. Bates, J.C. Blankenship, and et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 44 122
3. F. Zijlstra, J.C.A. Hoorntje, M.-J. de Boer, and et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction N Engl J Med 341 1999 1413 1419
4. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
5. P. Widimský, T. Budešínský, D. Voráč, and et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: final results of the randomized national multicentre trial - Prague-2 Eur Heart J 24 2003 94 104
6. H.R. Andersen, T.T. Nielsen, K. Rasmussen, and et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction N Engl J Med 349 2003 733 742
7. C. Stettler, S. Wandel, S. Allemann, and et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948
8. G.W. Stone, J.W. Moses, S.G. Ellis, and et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008
9. A. Kastrati, J. Mehilli, J. Pache, and et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 1030 1039
10. L. Mauri, W.-h. Hsieh, J.M. Massaro, and et al. Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
11. P.G. Steg, S.K. James, D. Atar, and et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) Eur Heart J 33 2012 2569 2619
12. C.W. Hamm, J.-P. Bassand, S. Agewall, and et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 32 2011 2999 3054
13. J.F. Santos, C. Aguiar, C. Gavina, and et al. Portuguese Registry of Acute Coronary Syndromes: seven years of activity Rev Port Cardiol 28 2009 1465 1500
14. W. Wijns, P. Kolh, N. Danchin, and et al. Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 31 2010 2501 2555
15. S. Ramcharitar, M. Hochadel, A.L. Gaster, and et al. An insight into the current use of drug eluting stents in acute and elective percutaneous coronary interventions in Europe. A report on the EuroPCI Survey EuroIntervention 3 2008 429 441
16. A. Dziewierz, Z. Siudak, T. Rakowski, and et al. Drug-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: a mortality analysis from the EUROTRANSFER Registry Clin Res Cardiol 100 2011 139 145
17. E. Camenzind, P.G. Steg, and W. Wijns Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern Circulation 115 2007 1440 1455
18. M.T. Roe, A.Y. Chen, C.P. Cannon, and et al. Temporal changes in the use of drug-eluting stents for patients with non-ST-segment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) and Acute Coronary Treatment and Intervention Outcomes Network-Get With The Guidelines (ACTION-GWTG) Registries Circ Cardiovasc Qual Outcomes 2 2009 414 420
19. S. Vasaiwala, D. Forman, and L. Mauri Drug-eluting stents in the elderly Curr Treat Options Cardiovasc Med 12 2010 76 83
20. K. Lakshminarayan, C.A. Solid, A.J. Collins, and et al. Atrial fibrillation and stroke in the general Medicare population: a 10-year perspective (1992 to 2002) Stroke 37 2006 1969 1974
21. T.Y. Wang, F.A. Masoudi, J.C. Messenger, and et al. Percutaneous coronary intervention and drug-eluting stent use among patients 85 years of age in the United States J Am Coll Cardiol 59 2012 105 112
22. P.S. Douglas, J.M. Brennan, K.J. Anstrom, and et al. Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry J Am Coll Cardiol 53 2009 1629 1641
23. S.V. Rao, R.E. Shaw, R.G. Brindis, and et al. Patterns and outcomes of drug-eluting coronary stent use in clinical practice Am Heart J 152 2006 321 326
24. R.G. Hart, O. Benavente, R. McBride, and et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis Ann Intern Med 131 1999 492 501
25. M. Nabauer, A. Gerth, T. Limbourg, and et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management Europace 11 2009 423 434
26. K. Mischke, C. Knackstedt, and N. Marx Anticoagulant and antiplatelet therapy in patients with atrial fibrillation and coronary artery disease Thrombosis 2012 2012 8
27. J.M. Ruiz-Nodar, F. Marín, J.A. Hurtado, and et al. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis J Am Coll Cardiol 51 2008 818 825
28. A. Sourgounis, J. Lipiecki, T.S. Lo, and et al. Coronary stents and chronic anticoagulation Circulation 119 2009 1682 1688
29. A.J. Camm, P. Kirchhof, G.Y.H. Lip, and et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Europace 12 2010 1360 1420
30. G. Lip, K. Huber, F. Andreotti, and et al. European Society of Cardiology Working Group on Thrombosis. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting Thromb Haemost 2010 13 28
31. D. Faxon, J. Eikelboom, P. Berger, and et al. Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective Thromb Haemost 2011 572 584
32. A. Rubboli, and F.W.A. Verheugt Antithrombotic treatment for patients on oral anticoagulation undergoing coronary stenting: a review of the available evidence and practical suggestions for the clinician Int J Cardiol 123 2008 234 239
33. I. Iakovou, T. Schmidt, E. Bonizzoni, and et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130
34. P. Roy, R. Torguson, T. Okabe, and et al. Angiographic and procedural correlates of stent thrombosis after intracoronary implantation of drug-eluting stents J Interv Cardiol 20 2007 307 313
35. P. Roy, T. Okabe, T.L. Pinto Slottow, and et al. Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents Am J Cardiol 100 2007 965 969
36. L. Bonello, A. De Labriolle, G. Lemesle, and et al. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries Am J Cardiol 103 2009 496 500
37. C. Stettler, S. Allemann, S. Wandel, and et al. Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis BMJ 2008 337
38. P.B. Parikh, A. Jeremias, S.S. Naidu, and et al. Determinants of bare-metal stent use in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention J Invasive Cardiol 25 2013 114 117
39. E.L. Hannan, M. Racz, G. Walford, and et al. Drug-eluting versus bare-metal stents in the treatment of patients with ST-segment elevation myocardial infarction JACC Cardiovasc Interv 1 2008 129 135
40. D.E. Kandzari, M.T. Roe, E.M. Ohman, and et al. Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes Am J Cardiol 96 2005 750 755
41. L. Mauri, T.S. Silbaugh, P. Garg, and et al. Drug-eluting or bare-metal stents for acute myocardial infarction N Engl J Med 359 2008 1330 1342